BioNTech gibt Kollaboration mit Regeneron zur Entwicklung einer Melanom-Kombinationstherapie aus FixVac und Libtayo® (Cemiplimab) bekannt

NEXT STORY
Germany Diabetes Market 2020 – By Continuous Glucose Monitoring, Blood Glucose Device, Insulin Pen, Insulin Pump, Reimbursement Company Analysis & Forecast
PREV STORY
Press release Biocartis Group NV: Invitation to the Extraordinary Shareholders’ Meeting
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AVITA Medical Reports Third Quarter 2021 Financial Results

author_avatar
NASDAQ Market News

Progenics Pharmaceuticals Announces First Patient Dosed in Phase 2/3 Clinical Trial of PSMA-Targeted PET/CT Imaging Agent PyL™

NEW YORK, Dec. 07, 2016 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology ...

author_avatar
NASDAQ Market News

Cellceutix Phase 2 Trial Initial Data Shows Potential of Brilacidin as a Novel Anti-Inflammatory Drug Candidate for the Induction of Remission of Mild-to-Moderate Ulcerative Colitis

BEVERLY, Mass., Oct. 10, 2016 (GLOBE NEWSWIRE) -- Cellceutix Corporation, (OTC: CTIX) (“the Company”), ...

author_avatar
NASDAQ Market News